Related Experiment Video
Updated: Oct 10, 2025

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Investigating the Convergent Mechanisms between Major Depressive Disorder and Parkinson's Disease
Angela A Tran1,2, Myra De Smet1, Gary D Grant3
1School of Medical Science, Griffith University, Southport, Queensland, Australia.
Abstract:
Major depressive disorder (MDD) affects more than cognition, having a temporal relationship with neuroinflammatory pathways of Parkinson's disease (PD). Although this association is supported by epidemiological and clinical studies, the underlying mechanisms are unclear. Microglia and astrocytes play crucial roles in the pathophysiology of both MDD and PD. In PD, these cells can be activated by misfolded forms of the protein α-synuclein to release cytokines that can interact with multiple different physiological processes to produce depressive symptoms, including monoamine transport and availability, the hypothalamus-pituitary axis, and neurogenesis. In MDD, glial cell activation can be induced by peripheral inflammatory agents that cross the blood-brain barrier and/or c-Fos signalling from neurons. The resulting neuroinflammation can cause neurodegeneration due to oxidative stress and glutamate excitotoxicity, contributing to PD pathology. Astrocytes are another major link due to their recognized role in the glymphatic clearance mechanism. Research suggesting that MDD causes astrocytic destruction or structural atrophy highlights the possibility that accumulation of α-synuclein in the brain is facilitated as the brain cannot adequately clear the protein aggregates. This review examines research into the overlapping pathophysiology of MDD and PD with particular focus on the roles of glial cells and neuroinflammation.
Insights
Major depressive disorder (MDD) and Parkinson's disease (PD) share overlapping neuroinflammatory pathways. Glial cells, particularly microglia and astrocytes, are key players in the pathophysiology of both conditions, influencing neurodegeneration and protein aggregate clearance.
Area of Science:
- Neuroscience
- Neuroinflammation
- Neurodegenerative Diseases
Background:
- Major depressive disorder (MDD) and Parkinson's disease (PD) exhibit a temporal relationship, suggesting shared underlying mechanisms.
- Microglia and astrocytes are implicated in the pathophysiology of both MDD and PD, acting as crucial mediators.
- Existing epidemiological and clinical studies support the association between MDD and PD, yet the precise mechanisms remain elusive.
Purpose of the Study:
- To review and examine the overlapping pathophysiology of MDD and PD.
- To elucidate the specific roles of glial cells (microglia and astrocytes) in the shared disease mechanisms.
- To highlight the contribution of neuroinflammation to the progression of both MDD and PD.
Main Methods:
- Review of existing scientific literature focusing on MDD, PD, glial cell function, and neuroinflammation.
- Analysis of research investigating the activation of microglia and astrocytes in response to α-synuclein and peripheral inflammatory agents.
- Examination of studies on the impact of neuroinflammation on monoamine transport, the hypothalamus-pituitary axis, neurogenesis, and glymphatic clearance.
Main Results:
- Activated microglia and astrocytes in PD release cytokines triggered by α-synuclein, contributing to depressive symptoms.
- Neuroinflammation in MDD, induced by inflammatory agents or neuronal signaling, can lead to neurodegeneration and exacerbate PD pathology.
- Astrocytic dysfunction in MDD may impair glymphatic clearance, potentially facilitating α-synuclein aggregate accumulation in PD.
Conclusions:
- Glial cell activation and neuroinflammation represent a significant link in the shared pathophysiology of MDD and PD.
- Dysfunctional glymphatic clearance due to astrocytic issues in MDD could play a role in PD pathogenesis.
- Further research into these overlapping mechanisms is crucial for developing effective therapeutic strategies for both conditions.
More Related Videos
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Neural Regulation